| 2026 |
| 07/30 | 304 | 308 | 303 | 307 | +0.99% | 10,300 | 19億6909万 | -3.76% |
| 07/29 | 307 | 307 | 301 | 304 | -0.98% | 23,800 | 19億4985万 | -4.4% |
| 07/28 | 307 | 309 | 303 | 307 | -0.65% | 31,100 | 19億6909万 | -3.46% |
| 07/27 | 309 | 313 | 303 | 309 | +0.98% | 27,700 | 19億8192万 | -2.52% |
| 07/24 | 310 | 314 | 305 | 306 | -2.24% | 27,700 | 19億6268万 | -3.47% |
| 07/24 | （空売り報告）Citigroup Global Markets Limited 60,400株（0.94%）+0.09% |
| 07/23 | （IR情報）12:00 第47回 日本炎症・再生医学会における研究発表のお知らせ |
| 07/23 | 309 | 314 | 309 | 313 | 0% | 12,100 | 20億758万 | -0.95% |
| 07/22 | 313 | 314 | 310 | 313 | -0.95% | 17,300 | 20億758万 | -0.95% |
| 07/22 | （空売り報告）Citigroup Global Markets Limited 54,700株（0.85%）+0.12% |
| 07/21 | 320 | 320 | 309 | 316 | -1.25% | 15,000 | 20億2682万 | +0.64% |
| 07/17 | 320 | 320 | 310 | 320 | -1.23% | 51,200 | 20億5248万 | +2.56% |
| 07/16 | 327 | 331 | 320 | 324 | -0.92% | 16,000 | 20億7813万 | +4.85% |
| 07/15 | 325 | 330 | 320 | 327 | -0.61% | 35,700 | 20億9737万 | +6.51% |
| 07/14 | 328 | 332 | 326 | 329 | -1.2% | 28,900 | 21億1020万 | +8.22% |
| 07/14 | （空売り報告）Citigroup Global Markets Limited 46,900株（0.73%）+0.13% |
| 07/13 | 335 | 336 | 330 | 333 | -1.48% | 45,200 | 21億3586万 | +10.63% |
| 07/10 | 340 | 341 | 336 | 338 | -0.59% | 34,500 | 21億6793万 | +13.42% |
| 07/09 | 347 | 347 | 337 | 340 | -2.3% | 52,000 | 21億8076万 | +15.25% |
| 07/09 | （空売り報告）Citigroup Global Markets Limited 38,600株（0.6%）+0.01% |
| 07/08 | 335 | 367 | 333 | 348 | +2.96% | 394,000 | 22億3207万 | +19.18% |
| 07/08 | （空売り報告）モルガン・スタンレーMUFG証券 31,200株（0.48%）-0.08%義務消失 |
| 07/08 | （空売り報告）Citigroup Global Markets Limited 37,900株（0.59%）再IN |
| 07/07 | 344 | 344 | 335 | 338 | -2.03% | 59,200 | 21億6793万 | +16.96% |
| 07/07 | （空売り報告）モルガン・スタンレーMUFG証券 36,400株（0.56%）-0.05% |
| 07/06 | 365 | 365 | 343 | 345 | -2.27% | 102,200 | 22億1283万 | +20.63% |
| 07/06 | （空売り報告）UBS AG 31,900株（0.49%）-0.04%義務消失 |
| 07/06 | （空売り報告）Nomura International plc 30,700株（0.47%）-0.05%義務消失 |
| 07/06 | （空売り報告）モルガン・スタンレーMUFG証券 39,700株（0.61%）再IN |
| 07/03 | 336 | 359 | 326 | 353 | +0.57% | 402,600 | 22億6414万 | +24.73% |
| 07/03 | （空売り報告）UBS AG 34,600株（0.53%）再IN |
| 07/03 | （空売り報告）Nomura International plc 33,400株（0.52%）-0.21% |
| 07/02 | （IR情報）12:00 第30回日本がん分子標的治療学会学術集会における研究発表のお知らせ |
| 07/02 | 351 | 369 | 335 | 351 | +18.98% | 1,074,900 | 22億5131万 | +25.81% |
| 07/02 | （空売り報告）Nomura International plc 46,900株（0.73%）再IN |
| 07/01 | （IR情報）16:00 中東情勢の緊迫化(続報2)および業績予想の修正に関するお知らせ |
| 07/01 | 291 | 298 | 291 | 295 | +2.08% | 9,800 | 18億9213万 | +6.88% |
| 06/30 | 291 | 291 | 287 | 289 | -0.69% | 11,100 | 18億5364万 | +5.09% |
| 06/29 | 289 | 291 | 289 | 291 | +0.69% | 16,900 | 18億6647万 | +6.2% |
| 06/26 | 290 | 291 | 289 | 289 | -0.34% | 6,100 | 18億5364万 | +5.47% |
| 06/25 | 290 | 294 | 290 | 290 | 0% | 4,000 | 18億6006万 | +6.23% |
| 06/24 | 298 | 298 | 290 | 290 | -1.69% | 11,900 | 18億6006万 | +6.62% |
| 06/23 | 293 | 299 | 288 | 295 | +0.68% | 27,400 | 18億9213万 | +8.86% |
| 06/22 | 286 | 295 | 279 | 293 | +1.74% | 50,100 | 18億7930万 | +8.92% |
| 06/19 | 304 | 304 | 278 | 288 | -4.64% | 123,000 | 18億4723万 | +7.46% |
| 06/18 | 301 | 307 | 281 | 302 | -2.27% | 280,100 | 19億3702万 | +13.11% |
| 06/17 | 266 | 315 | 266 | 309 | +21.18% | 1,152,400 | 19億8192万 | +15.73% |
| 06/16 | （IR情報）16:00 中東情勢の緊迫化による影響(続報)のお知らせ |
| 06/16 | 261 | 261 | 253 | 255 | -2.3% | 31,700 | 16億3557万 | -4.85% |
| 06/15 | 264 | 264 | 259 | 261 | +0.77% | 34,400 | 16億7405万 | -3.69% |
| 06/12 | 258 | 262 | 258 | 259 | +0.39% | 3,400 | 16億6122万 | -5.47% |
| 06/11 | 263 | 263 | 257 | 258 | 0% | 18,600 | 16億5481万 | -6.86% |
| 06/10 | 260 | 262 | 258 | 258 | -1.15% | 13,500 | 16億5481万 | -7.86% |
| 06/09 | 263 | 264 | 261 | 261 | -0.76% | 6,100 | 16億7405万 | -7.45% |
| 06/08 | 263 | 275 | 260 | 263 | -0.38% | 17,200 | 16億8688万 | -7.72% |
| 06/05 | 265 | 266 | 263 | 264 | 0% | 5,100 | 16億9329万 | -8.01% |
| 06/04 | 262 | 265 | 261 | 264 | +0.76% | 7,400 | 16億9329万 | -8.97% |
| 06/03 | 262 | 264 | 262 | 262 | 0% | 8,200 | 16億8046万 | -10.27% |
| 06/02 | 266 | 267 | 262 | 262 | -0.76% | 14,500 | 16億8046万 | -11.19% |
| 06/01 | 271 | 271 | 263 | 264 | -2.58% | 25,600 | 16億9329万 | -11.11% |
| 05/29 | 268 | 271 | 268 | 271 | +1.12% | 3,800 | 17億3819万 | -9.67% |
| 05/28 | 270 | 271 | 268 | 268 | -1.47% | 11,600 | 17億1895万 | -11.55% |
| 05/27 | 275 | 275 | 270 | 272 | 0% | 6,000 | 17億4460万 | -11.11% |
| 05/26 | 266 | 274 | 266 | 272 | +1.49% | 24,500 | 17億4460万 | -11.69% |
| 05/25 | 266 | 271 | 266 | 268 | -0.74% | 21,700 | 17億1895万 | -13.83% |
| 05/22 | 266 | 270 | 264 | 270 | +1.5% | 18,100 | 17億3178万 | -13.74% |
| 05/21 | 267 | 268 | 256 | 266 | +1.53% | 30,900 | 17億612万 | -15.82% |
| 05/20 | （IR情報）16:00 役員人事内定および人事異動に関するお知らせ |
| 05/20 | （IR情報）16:00 資本金および資本準備金の額の減少に関するお知らせ |
| 05/20 | （IR情報）16:00 剰余金の配当に関するお知らせ |
| 05/20 | 265 | 269 | 261 | 262 | -1.13% | 16,100 | 16億8046万 | -17.87% |
| 05/19 | 264 | 266 | 255 | 265 | +3.52% | 44,400 | 16億9971万 | -17.7% |
| 05/18 | 270 | 273 | 248 | 256 | -5.88% | 131,100 | 16億4198万 | -21.23% |
| 05/15 | 290 | 290 | 268 | 272 | -8.42% | 127,700 | 17億4460万 | -17.07% |
| 05/14 | （IR情報）16:00 令和8年3月期決算短信〔日本基準〕(非連結) |
| 05/14 | （IR情報）16:00 中東情勢の緊迫化による影響および令和9年3月期の業績予想についてのお知らせ |
| 05/14 | （IR情報）16:00 優先株式に係る剰余金の配当に関するお知らせ |
| 05/14 | 322 | 322 | 291 | 297 | -10.27% | 96,700 | 19億495万 | -10.27% |
| 05/13 | （IR情報）16:00 業績予想の修正に関するお知らせ |
| 05/13 | 330 | 334 | 330 | 331 | +0.3% | 4,300 | 21億2303万 | -0.3% |
| 05/12 | 335 | 335 | 330 | 330 | -1.49% | 6,700 | 21億1662万 | -0.9% |
| 05/11 | 332 | 335 | 332 | 335 | +1.21% | 10,700 | 21億4869万 | +0.6% |
| 05/08 | 331 | 332 | 327 | 331 | 0% | 5,200 | 21億2303万 | -0.6% |
| 05/07 | 326 | 331 | 326 | 331 | +2.8% | 11,900 | 21億2303万 | -0.6% |
| 05/01 | 323 | 325 | 321 | 322 | 0% | 9,400 | 20億6530万 | -3.59% |
| 04/30 | 321 | 327 | 321 | 322 | -0.62% | 8,600 | 20億6530万 | -4.17% |
| 04/28 | 322 | 325 | 322 | 324 | +0.31% | 4,700 | 20億7813万 | -3.86% |
| 04/27 | 325 | 326 | 320 | 323 | -0.62% | 6,700 | 20億7172万 | -4.44% |
| 04/24 | 329 | 329 | 324 | 325 | -0.91% | 9,800 | 20億8455万 | -4.41% |
| 04/23 | 330 | 336 | 328 | 328 | -0.91% | 10,100 | 21億379万 | -4.09% |
| 04/22 | 340 | 342 | 331 | 331 | -2.36% | 12,100 | 21億2303万 | -4.06% |
| 04/21 | 341 | 347 | 339 | 339 | -1.17% | 3,400 | 21億7434万 | -2.31% |
| 04/20 | 334 | 345 | 330 | 343 | +3% | 14,500 | 22億 | -1.72% |
| 04/17 | 334 | 337 | 333 | 333 | 0% | 2,800 | 21億3586万 | -5.13% |
| 04/16 | 338 | 339 | 331 | 333 | -0.6% | 7,100 | 21億3586万 | -5.93% |
| 04/15 | 330 | 338 | 330 | 335 | +1.52% | 4,000 | 21億4869万 | -6.16% |
| 04/14 | 336 | 337 | 328 | 330 | -1.79% | 19,400 | 21億1662万 | -8.08% |
| 04/13 | 340 | 343 | 336 | 336 | -1.18% | 4,600 | 21億5510万 | -7.18% |
| 04/10 | 342 | 343 | 339 | 340 | -0.58% | 8,500 | 21億8076万 | -6.59% |
| 04/09 | 341 | 344 | 341 | 342 | +0.29% | 7,000 | 21億9358万 | -6.56% |
| 04/08 | 340 | 344 | 336 | 341 | +1.79% | 16,500 | 21億8717万 | -7.34% |
| 04/07 | 335 | 339 | 332 | 335 | +1.52% | 16,100 | 21億4869万 | -9.7% |
| 04/06 | 337 | 337 | 330 | 330 | -2.08% | 19,900 | 21億1662万 | -11.53% |
| 04/03 | 340 | 342 | 333 | 337 | -0.3% | 7,300 | 21億6151万 | -10.61% |
| 04/02 | 342 | 342 | 334 | 338 | -0.88% | 18,000 | 21億6793万 | -11.05% |
| 04/01 | 339 | 341 | 337 | 341 | +2.71% | 20,100 | 21億8717万 | -10.97% |
| 03/31 | 331 | 340 | 328 | 332 | -1.78% | 27,200 | 21億2944万 | -13.99% |
| 03/30 | 341 | 343 | 333 | 338 | -3.98% | 19,100 | 21億6793万 | -13.11% |
| 03/27 | （IR情報）16:00 日本薬学会第146年会における研究発表のお知らせ（1） |
| 03/27 | 352 | 358 | 346 | 352 | -2.22% | 43,700 | 22億5772万 | -10.43% |
| 03/26 | 366 | 369 | 360 | 360 | -1.37% | 14,100 | 23億904万 | -9.09% |
| 03/25 | （IR情報）16:00 組織変更およ人事異動に関するお知らせ |
| 03/25 | 362 | 368 | 360 | 365 | +2.82% | 11,000 | 23億4111万 | -8.29% |
| 03/24 | 355 | 364 | 353 | 355 | +0.85% | 12,900 | 22億7697万 | -11.03% |
| 03/23 | 380 | 384 | 316 | 352 | -8.81% | 153,500 | 22億3238万 | -12.22% |
| 03/19 | 392 | 392 | 385 | 386 | -2.28% | 4,000 | 24億4801万 | -3.98% |
| 03/18 | （IR情報）16:00 日本化学会第106回春季年会における研究発表のお知らせ |
| 03/18 | 401 | 401 | 390 | 395 | +0.25% | 7,400 | 25億509万 | -1.74% |
| 03/17 | （IR情報）16:00 第99回日本薬理学会年会における研究発表のお知らせ |
| 03/17 | 388 | 394 | 384 | 394 | +1.55% | 10,500 | 24億9874万 | -1.75% |
| 03/16 | 390 | 400 | 380 | 388 | -2.51% | 26,400 | 24億6069万 | -3.24% |
| 03/13 | 405 | 405 | 377 | 398 | -2.45% | 74,900 | 25億2411万 | -0.5% |
| 03/12 | 405 | 408 | 398 | 408 | +2% | 24,400 | 25億8753万 | +2.26% |
| 03/11 | 399 | 412 | 399 | 400 | +2.3% | 17,000 | 25億3680万 | +0.5% |
| 03/10 | 397 | 400 | 391 | 391 | +0.26% | 4,500 | 24億7972万 | -1.26% |
| 03/09 | 382 | 390 | 382 | 390 | -1.52% | 7,900 | 24億7338万 | -1.52% |
| 03/06 | 398 | 402 | 396 | 396 | -0.5% | 5,800 | 25億1143万 | +0.25% |
| 03/05 | 397 | 401 | 397 | 398 | +4.46% | 6,400 | 25億2411万 | +1.02% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
